Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

Nature

Volumn 417, Issue 6884, 2002, Pages 74-78

  Zhu, Shan ^a   Stavrovskaya, Irina G ^b   Drozda, Martin ^a   Kim, Betty Y S ^a   Ona, Victor ^a   Li, Mingwel ^a   Sarang, Satinder ^a   Liu, Allen S ^a   Hartley, Dean M ^a   Wu, Du Chu ^c   Guilans, Steven ^a   Ferrante, Robert J ^d,e   Przedborski, Serge ^a,c   Kristal, Bruce S ^b,f   Friedlander, Robert M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BURKE MEDICAL RESEARCH INSTITUTE   (United States)

^c Brigham and Women’s Hospital ^*  (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; BRAIN; CELLS; DISEASES; ENZYMES; NITROGEN OXIDES;

MINOCYCLINES;

CYTOLOGY;

CASPASE 3; CYTOCHROME C; INTERLEUKIN 1BETA CONVERTING ENZYME; MINOCYCLINE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE SYNTHASE;

PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG PENETRATION; DRUG SAFETY; ENZYME INHIBITION; ENZYME RELEASE; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME;

AGE OF ONSET; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CASPASES; CELL DEATH; CELLS, CULTURED; CEREBRAL CORTEX; CYTOCHROME C GROUP; DISEASE PROGRESSION; ENZYME ACTIVATION; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIA; MICE; MICE, INBRED C57BL; MINOCYCLINE; MITOCHONDRIA; MITOCHONDRIAL SWELLING; N-METHYLASPARTATE; PERMEABILITY; RATS; SURVIVAL RATE; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0037007645     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/417074a     Document Type: Article

References (30)

1. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
2. Munocycline inhibits caspase-1 and caspase- 3 expression and delays mortality in a transgenic mouse model of Huntington disease
3. Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction
4. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicty by inhibiting activation and proliferation of microglia
5. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson disease
6. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease
7. Inhibition of ICE slows ALS in mice
8. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis
9. Functional role of caspase-1 and caspase- 3 in an ALS transgenic mouse model
10. Minocycline: A review of its antibacterial and pharmacokinetic properties and therapeutic use
11. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease
12. Amyotrophic lateral sclerosis
13. Mutations in Cu/Zn superoxide dismutase dismutase gene are associated with familial amyotrophic lateral sclerosis
14. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation
15. An adverse property of a familial ALS-linked SOD 1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria
16. Mitochondria and apoptosis
17. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
18. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
19. Bid acts on the permeability transition pore complex to induce apoptosis
20. Mitochondria and cell death. Mechanistic aspects and methodological issues
21. Mitochondrial permeability transition in the central nervous system: Induction by calcium cycling-dependent and -independent pathways
22. Differences in the activation of the mitochondrial permeability transition among brain regions in the rat correlate with selective vulnerability
23. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC
24. Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis
25. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons
26. Expression of a dominant negative mutant of Interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury
27. Apoptogenic ganglioside GD 3 directly induces the mitochondrial permeability transition
28. Preparation of synaptic and nonsynaptic mitochondria from mammalian brain
29. Biochemical characterization of the mitochondrial permeability transition in isolated forebrain mitochondria
30. 2+-induced pore opening in mitochondria energized by succinate-ferricyanide electron transport